Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets
Fan Guan,
No information about this author
Ruixuan Wang,
No information about this author
Zhenjie Yi
No information about this author
et al.
Signal Transduction and Targeted Therapy,
Journal Year:
2025,
Volume and Issue:
10(1)
Published: March 7, 2025
Abstract
Macrophages
are
immune
cells
belonging
to
the
mononuclear
phagocyte
system.
They
play
crucial
roles
in
defense,
surveillance,
and
homeostasis.
This
review
systematically
discusses
types
of
hematopoietic
progenitors
that
give
rise
macrophages,
including
primitive
progenitors,
erythro-myeloid
stem
cells.
These
have
distinct
genetic
backgrounds
developmental
processes.
Accordingly,
macrophages
exhibit
complex
diverse
functions
body,
phagocytosis
clearance
cellular
debris,
antigen
presentation,
response,
regulation
inflammation
cytokine
production,
tissue
remodeling
repair,
multi-level
regulatory
signaling
pathways/crosstalk
involved
homeostasis
physiology.
Besides,
tumor-associated
a
key
component
TME,
exhibiting
both
anti-tumor
pro-tumor
properties.
Furthermore,
functional
status
is
closely
linked
development
various
diseases,
cancer,
autoimmune
disorders,
cardiovascular
disease,
neurodegenerative
metabolic
conditions,
trauma.
Targeting
has
emerged
as
promising
therapeutic
strategy
these
contexts.
Clinical
trials
macrophage-based
targeted
drugs,
immunotherapies,
nanoparticle-based
therapy
were
comprehensively
summarized.
Potential
challenges
future
directions
targeting
also
been
discussed.
Overall,
our
highlights
significance
this
versatile
cell
human
health
which
expected
inform
research
clinical
practice.
Language: Английский
Caspase family in autoimmune diseases
Wangzheqi Zhang,
No information about this author
Huang Wu,
No information about this author
Yan Liao
No information about this author
et al.
Autoimmunity Reviews,
Journal Year:
2024,
Volume and Issue:
24(2), P. 103714 - 103714
Published: Dec. 3, 2024
Language: Английский
Macrophages Unmasked: Their Pivotal Role in Driving Atherosclerosis in Systemic Lupus Erythematosus
Chao Wang,
No information about this author
B Chen,
No information about this author
Xiaochen Yu
No information about this author
et al.
Clinical Reviews in Allergy & Immunology,
Journal Year:
2025,
Volume and Issue:
68(1)
Published: Feb. 7, 2025
Language: Английский
The role of pyroptosis in environmental pollutants-induced multisystem toxicities
Rui Xu,
No information about this author
Longfei Li,
No information about this author
Yijia Ke
No information about this author
et al.
Life Sciences,
Journal Year:
2025,
Volume and Issue:
372, P. 123632 - 123632
Published: April 10, 2025
Language: Английский
Identification of mitochondrial function and programmed cell death associated key biomarkers and the circRNA-miRNA-mRNA regulatory network in systemic lupus erythematosus
Junjie Cao,
No information about this author
Aifang Li,
No information about this author
Hui Zhou
No information about this author
et al.
Frontiers in Molecular Biosciences,
Journal Year:
2025,
Volume and Issue:
12
Published: April 14, 2025
Objectives
Systemic
Lupus
Erythematosus
(SLE)
is
a
highly
heterogeneous
autoimmune
disease
with
complex
pathogenic
mechanisms.
Mitochondrial
function
and
programmed
cell
death
(PCD)
play
important
roles
in
SLE.
This
study
aims
to
screen
biomarkers
related
mitochondrial
SLE
analyze
their
underlying
Methods
SLE-related
databases
were
derived
from
the
GEO
database,
where
three
merged
into
one
database
as
training
set.
Genes
PCD
sourced
MitoCarta
3.0
database.
Key
genes
identified
through
bioinformatics
machine
learning,
expression
levels
diagnostic
efficacy
validated
using
two
datasets
validation
The
relationship
between
immune
cells
was
analyzed
CIBERSORT
infiltration
analysis.
Diagnostic
genes-related
miRNAs
predicted
online
databases.
Differential
circRNAs
screened
circRNA
datasets,
circbank,
finally
constructing
circRNA-miRNA-mRNA
ceRNA
regulatory
network.
Results
From
448
differential
set,
key
genes,
IFI27
LAMP3,
learning
WGCNA.
Enrichment
analysis
revealed
that
they
mainly
enriched
pathways
such
cycle,
systemic
lupus
erythematosus,
cytosolic
DNA
sensing
pathway,
toll-like
receptor
(TLR)
signaling
pathway
nod-like
(NLR)
pathway.
Immune
found
compared
normal
group,
11
differentially
expressed,
9
types
of
LAMP3
10
cells.
final
constructed
network
consists
2
mRNAs,
5
miRNAs,
4
circRNAs.
Conclusion
Our
ultimately
(IFI27
LAMP3)
an
role
In
future,
have
potential
become
diagnosis
treatment
Their
response
may
provide
new
strategies
for
Language: Английский
The Onset of Systemic Lupus Erythematosus Triggers Nucleus Pulposus Cell Pyroptosis to Exacerbate Intervertebral Disc Degeneration
Zhaobai Lao,
No information about this author
X. Fang,
No information about this author
Shuchao Shen
No information about this author
et al.
Journal of Inflammation Research,
Journal Year:
2024,
Volume and Issue:
Volume 17, P. 7705 - 7719
Published: Oct. 1, 2024
Systemic
lupus
erythematosus
(SLE)
is
an
autoimmune
disorder
marked
by
immune
system
dysregulation
and
autoantibodies
production,
causing
widespread
inflammation
damage
across
various
body
systems.
Despite
the
prevalent
back
pain
in
SLE
patients,
link
between
intervertebral
disc
(IVD)
degeneration,
a
primary
contributor
to
pain,
remains
inadequately
understood.
This
study
explored
impact
of
on
IVD
degeneration
using
MRL/
Language: Английский
Pyroptosis‐Inducing Self‐Adaptor to Potentiate Immune Checkpoint Blockade Therapy for Breast Cancer by Reeducating the Treatment‐Recruited Macrophages
Ziwen Qiu,
No information about this author
Yingtao Zhong,
No information about this author
Zhen‐Ming Lu
No information about this author
et al.
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 31, 2024
Abstract
Treatment‐induced
cell
pyroptosis
can
improve
the
immunogenicity
of
breast
cancer
and
enhance
efficacy
immune
checkpoint
blockade
(ICB),
but
resultant
recruitment
immunosuppressive
cells
impedes
systemic
anti‐tumor
immunity.
Herein,
a
rationally
designed
self‐adaptor
(R@L‐MRS17)
is
developed
to
initiate
concomitantly
reeducate
pyroptosis‐recruited
macrophages
ICB
therapy.
Of
which,
R@L‐MRS17
promotes
cancer‐specific
drug
delivery
through
CD47
recognition,
enables
plasma
membrane
targeted
photosensitizer
insertion
hydrophobic
electrostatic
interactions.
Under
light
excitation,
produces
reactive
oxygen
species
(ROS)
in
situ
trigger
pyroptosis,
followed
by
release
pro‐inflammatory
factors
recruit
tumor
immunogenicity.
Moreover,
acid
responsiveness
facilitates
R848
polarize
infiltrated
into
M1
phenotype
for
active
Additionally,
capable
blocking
restore
recognition
phagocytosis
behavior
M1‐type
against
cells.
In
short,
stepwise
activation
significantly
suppresses
bilateral
growth
metastasis
combination
with
αPD‐L1.
This
study
provides
self‐adaptable
strategy
activate
immunological
cascade,
which
may
spatiotemporally
amplify
responses
cancer.
Language: Английский